Exchange Traded Concepts, LLC
- SEC CIK
- 0001457320
- Latest filing
- Aug 11, 2026
ZYNE holding history
Zynerba Pharmaceuticals, Inc. in every 13F filed by Exchange Traded Concepts, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZYNE overviewAll 13F holders of ZYNEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −18,733−100.0% | Sold out | Holders |
| Q4 2022 | 18,733 | $9.93K | <0.1% | +11,562+161.2% | Added | Holders |
| Q3 2022 | 7,171 | $5.00K | <0.1% | +1,018+16.5% | Added | Holders |
| Q2 2022 | 6,153 | $7.00K | <0.1% | +4,825+363.3% | Added | Holders |
| Q1 2022 | 1,328 | $3.00K | <0.1% | +1,328 | New | Holders |